Siliq 210 mg (Brodalumab SOLUTION) 210 MG

SILIQ 210 MG is a subcutaneous solution containing brodalumab, used for managing moderate to severe plaque psoriasis. This medication is designed to help reduce skin inflammation and improve skin appearance.

Strength

210 MG

Pack Size

2X1.5ML

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SILIQ 210 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults. Plaque psoriasis is a chronic skin condition characterized by red, itchy, and scaly patches. This medication works by targeting specific proteins in the body that contribute to inflammation and skin cell overproduction. Patients often wonder, 'What is SILIQ used for?' and the answer is that it is specifically formulated to help manage the symptoms of plaque psoriasis.

Side Effects

Common effects of SILIQ 210 MG may include redness, itching, or swelling at the injection site. Some users might experience fatigue, headache, or upper respiratory infections. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

SILIQ 210 MG should be handled with care, ensuring proper storage and administration. It is important to follow the prescribed guidelines for subcutaneous injection. Patients with a history of allergic reactions to brodalumab or any of the ingredients should avoid using this medication. Always inform your healthcare provider about any pre-existing conditions before starting treatment.

Avoid Interactions

SILIQ 210 MG may interact with other medications, including those that affect the immune system. It is advisable to avoid alcohol while using this medication, as it may exacerbate certain side effects. Patients should also be cautious when using other subcutaneous treatments simultaneously. Always consult a healthcare provider for personalized advice on managing potential interactions.

References

Frequently Asked Questions

SILIQ 210 MG is used for the treatment of moderate to severe plaque psoriasis in adults.

SILIQ 210 MG is administered via subcutaneous injection, typically into the abdomen, thigh, or upper arm.

Common side effects may include redness, itching, or swelling at the injection site, fatigue, headache, and upper respiratory infections.

SILIQ 210 MG may interact with other medications, especially those that affect the immune system. Always consult a healthcare provider before combining treatments.

SILIQ 210 MG is not suitable for everyone, particularly those with a history of allergic reactions to brodalumab or any of its ingredients.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.